View in EDS

1034P Phase I/II dose escalation and dose expansion study of TransCon IL-2 β/γ alone or in combination with pembrolizumab: Determination of recommended phase II dose (RP2D) for monotherapy.

Saved in:
Bibliographic Details
Title: 1034P Phase I/II dose escalation and dose expansion study of TransCon IL-2 β/γ alone or in combination with pembrolizumab: Determination of recommended phase II dose (RP2D) for monotherapy.
Authors: Starodub, A.N.1 (AUTHOR), Kim, S-B.2 (AUTHOR), Davar, D.3 (AUTHOR), Powderly, J.4 (AUTHOR), Hill, A.G.5 (AUTHOR), Yeku, O.6 (AUTHOR), Gabrail, N.7 (AUTHOR), Krapp, C.8 (AUTHOR), Pihl, S.9 (AUTHOR), Chen, M.10 (AUTHOR), Slavsky, S.11 (AUTHOR), Torrejon Castro, D.11 (AUTHOR), Singel, S.M.12 (AUTHOR), Kwatra, V.13 (AUTHOR)
Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS628-S628. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 173098968
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 1034P Phase I/II dose escalation and dose expansion study of TransCon IL-2 β/γ alone or in combination with pembrolizumab: Determination of recommended phase II dose (RP2D) for monotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Starodub%2C+A%2EN%2E%22">Starodub, A.N.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kim%2C+S-B%2E%22">Kim, S-B.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Davar%2C+D%2E%22">Davar, D.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Powderly%2C+J%2E%22">Powderly, J.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hill%2C+A%2EG%2E%22">Hill, A.G.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yeku%2C+O%2E%22">Yeku, O.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gabrail%2C+N%2E%22">Gabrail, N.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Krapp%2C+C%2E%22">Krapp, C.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pihl%2C+S%2E%22">Pihl, S.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+M%2E%22">Chen, M.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Slavsky%2C+S%2E%22">Slavsky, S.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Torrejon+Castro%2C+D%2E%22">Torrejon Castro, D.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Singel%2C+S%2EM%2E%22">Singel, S.M.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kwatra%2C+V%2E%22">Kwatra, V.</searchLink><relatesTo>13</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2023 Supplement 2, Vol. 34, pS628-S628. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=173098968
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2023.09.2173
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S628
    Titles:
      – TitleFull: 1034P Phase I/II dose escalation and dose expansion study of TransCon IL-2 β/γ alone or in combination with pembrolizumab: Determination of recommended phase II dose (RP2D) for monotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Starodub, A.N.
      – PersonEntity:
          Name:
            NameFull: Kim, S-B.
      – PersonEntity:
          Name:
            NameFull: Davar, D.
      – PersonEntity:
          Name:
            NameFull: Powderly, J.
      – PersonEntity:
          Name:
            NameFull: Hill, A.G.
      – PersonEntity:
          Name:
            NameFull: Yeku, O.
      – PersonEntity:
          Name:
            NameFull: Gabrail, N.
      – PersonEntity:
          Name:
            NameFull: Krapp, C.
      – PersonEntity:
          Name:
            NameFull: Pihl, S.
      – PersonEntity:
          Name:
            NameFull: Chen, M.
      – PersonEntity:
          Name:
            NameFull: Slavsky, S.
      – PersonEntity:
          Name:
            NameFull: Torrejon Castro, D.
      – PersonEntity:
          Name:
            NameFull: Singel, S.M.
      – PersonEntity:
          Name:
            NameFull: Kwatra, V.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 10
              Text: 2023 Supplement 2
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 34
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1